Velphoro for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis

Velphoro (sucroferric oxyhydroxide / PA21) is an iron-based Ca-free phosphate binder for treating Hyperphosphatemia in Chronic Kidney Disease (CKD) patients on dialysis.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news